JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB209064

Anti-TMEM119 antibody [28-3] - Microglial marker

  • BOND RX™ Validated
  • KO Validated
  • RabMAb
  • Recombinant
  • Lab Essentials
  • 20ul selling size
  • What is this?

4

(23 Reviews)

|

(205 Publications)

Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) is a rabbit monoclonal antibody detecting TMEM119 in IHC-P, IHC-Fr. Suitable for Mouse.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 130 publications

View Alternative Names

Transmembrane protein 119, Osteoblast induction factor, OBIF, Tmem119

14 Images
Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

AbReview59215****

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

ab209064 staining TMEM119 in Mouse corpus callosum sections by Immunohistochemistry (IHC-Fr - frozen sections). Tissue was fixed with paraformaldehyde and blocked with 0.5% BSA for 1 hour at 23°C. Samples were incubated with primary antibody at 1.4μg/ml for 18 hours at 4°C. An Alexa Fluor® 488 -conjugated Donkey anti-rabbit IgG polyclonal was used as the secondary antibody.

TMEM119 (green), Iba1 (red) and DAPI (blue)

This image is courtesy of an anonymous Abreview

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

Lab

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

IHC image of TMEM119 staining in a section of frozen normal mouse brain wild type (upper panel) and TMEM119 knockout (lower panel). No antigen retrieval step was performed prior to staining. Non-specific protein-protein interactions were then blocked in PBS containing 0.5% (v/v) Triton X-100, 0.3 M (w/v) glycine and 1% (w/v) BSA for 1 h at room temperature. The section was then incubated overnight at +4°C in PBS containing 0.5% (v/v) Triton X-100 and 1% (w/v) BSA with ab209064 at 0.5 μg/ml. The secondary antibody was ab150087 (shown in red) used at 2 μg/ml for 1 hour at room temperature. Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®. Images were taken with a confocal microscope (Leica-Microsystems, TCS SP8).

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

Collaborator

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

Normal (WT) mouse brain, stained for TMEM119 (red), Iba1 (green) and DAPI (blue). Samples were baked onto slides for 10 minutes at 60oC, rehydrated with PBS and blocked with blocking buffer (10% serum in PBST). ab209064 at a concentration of 1 μg/mL was incubated with the sample overnight at 4oC. Slides were washed with PBS and a goat anti-rabbit Alexa Fluor 488® was used as the secondary antibody at a concentration of 4 μg/mL.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

ab209064 at 1 : 2000 staining TMEM119 antibody in mouse cerebrum tissue by immunohistochemistry (FFPE). Immunohistochemical analysis of paraffin-embedded mouse cerebrum tissue labeling TMEM119 with ab209064 at 1/2000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP). Positive staining on glial cells in mouse cerebrum is observed. Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0) before commencing with IHC staining protocol. Counter stained with hematoxylin.

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

Lab

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

IHC image of TMEM119 staining in a section of frozen normal mouse brain. No antigen retrieval step was performed prior to staining. Non-specific protein-protein interactions were then blocked in PBS containing 0.5% (v/v) Triton X-100, 0.3 M (w/v) glycine and 1% (w/v) BSA for 1 h at room temperature. The section was then incubated overnight at +4°C in PBS containing 0.5% (v/v) Triton X-100 and 1% (w/v) BSA with ab209064 at 0.5 μg/ml. The secondary antibody was ab150087 (shown in red) used at 2 μg/ml for 1 hour at room temperature. Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®. The image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

IHC image of TMEM119 and Iba1 co-staining in a section of formalin-fixed paraffin-embedded normal mouse brain. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked in PBS containing 0.5% (v/v) Triton X-100, 0.3 M (w/v) glycine and 1% (w/v) BSA for 1 h at room temperature. The section was then incubated overnight at +4°C in TBS containing 0.5% (v/v) Triton X-100 and 1% (w/v) BSA with ab209064 at 1 μg/ml and ab5076 at 5 μg/ml. The secondary antibodies were ab150087 (shown in red) and ab150133 (shown in green) used at 2 μg/ml for 1 hour at room temperature. Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®. Images were taken with a confocal microscope (Leica-Microsystems, TCS SP8).

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

Collaborator

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

Normal mouse choroid plexus, stained for TMEM119 (red), Iba1 (green) and DAPI (blue). Choroid plexus macrophages are positive for Iba1 and negative for TMEM119. Samples were baked onto slides for 10 minutes at 60oC, rehydrated with PBS and blocked with blocking buffer (10% serum in PBST). ab209064 at a concentration of 1 μg/mL was incubated with the sample overnight at 4oC. Slides were washed with PBS and a goat anti-rabbit Alexa Fluor 488® was used as the secondary antibody at a concentration of 4 μg/mL.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

IHC image of TMEM119 staining in a section of formalin fixed, paraffin embedded normal mouse brain. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked in PBS containing 0.5% (v/v) Triton X-100, 0.3 M (w/v) glycine and 1% (w/v) BSA for 1 h at room temperature. The section was then incubated overnight at +4°C in PBS containing 0.5% (v/v) Triton X-100 and 1% (w/v) BSA with ab209064 at 0.1 μg/ml. The secondary antibody was ab150087 (shown in red) used at 2 μg/ml for 1 hour at room temperature. Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®. The image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

PubMed

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

Representative FISH analysis of GAS5 (green) co‐stained with ab209064 (red) in spinal cord sections from EAE mice at 30 dpi. Arrows indicate GAS5+TMEM119+ cells. Scale bars = 25 μm.

Female C57BL/6 mice (6–8 weeks) were deeply anesthetized with 3% chloral hydrate and a laminectomy was performed. After fixing the spine, 1 μl of 1% lysolecithin in a 0.9% sodium chloride solution was injected into the dorsal funiculus at the level of the T11–T12 vertebrae. The day of lysolecithin injection was designated day 0 (0 dpi). The spinal cord around the injection point was isolated and cut into serial cryosections.

Tissue sections were fixed, permeabilized, and incubated with the primary antibody overnight at 4°C, followed by 2 h of incubation with TRITC‐ or FITC‐conjugated secondary antibodies. Then, the samples were counterstained with Hoechst 33342.

Image from Sun D et al., EMBO Rep.. 2017;18(10):1801-1816. Fig EV3.; doi: 10.15252/embr.201643668. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Immunohistochemistry (PFA perfusion fixed frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-FoFr

Lab

Immunohistochemistry (PFA perfusion fixed frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

IHC image of TMEM119 staining in a section of Mouse cerebrum using ab209064 at 1 : 50 dilution.The section was fixed with 4% PFA then permeabilized with 0.2% Triton X-100. The secondary antibody was ab150081, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed used at 1 : 1000 dilution. Nuclear DNA was labelled with DAPI (shown in blue). Heat mediated antigen retrieval using sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20). Secondary antibody only control : PBS instead of the primary antibody.

Positive staining on mouse cerebrum.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

IHC image of TMEM119 staining in a section of formalin fixed, paraffin embedded normal mouse brain, performed on a Leica Bond™ system using the standard protocol B. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab209064, 0.5 μg/ml, for 15 mins at room temperature. A goat anti-Rabbit biotinylated secondary antibody was used to detect the primary, and visualized using an HRP conjugated ABC system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-Fr

PubMed

Immunohistochemistry (Frozen sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

Representative images of sham (d–g) and hypoperfusion (h–k) at 12 weeks post-surgery are shown to illustrate Iba-1 immunostaining in sham (d) and hypoperfused (h); TMEM119 immunostaining in sham (e) and hypoperfused (i) and then Iba-1/TMEM119 co-localisation in sham (f,g) and hypoperfused (j,k) white matter. All Iba-1+ cells in both sham and hypoperfused cohorts were also TMEM119+ indicating that the cells in the corpus callosum were resident microglia. Scale bars; d-f and h-j are 50μm, g and k 10 μm. The number of microglial cells significantly correlated with nodal gap length.

Free floating cryo-preserved sections cut at 30 μm thickness. Sections were incubated with the primary antibodies (anti-Iba-1 (1/100) and anti-TMEM119 (1/500, ab209064)) overnight at 4°C. Sections were stained at the outset with haematoxylin and eosin to determine the presence and absence of ischemic neuronal perikaryal damage as part of the inclusion/exclusion criteria.

Image from Manso Y et al., Glia. 2018;66(1):34-46. Fig 4.; doi: 10.1002/glia.23190 Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

Immunohistochemical analysis of formalin fixed paraffin embedded mouse cerebrum labelling TMEM119 with ab209064 at 1/1000 dilution. The secondary used was ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution. Sections were counterstained with DAPI. Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Positive staining on microglial cells of mouse cerebrum. The section was incubated with ab209064 at 4°C overnight.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TMEM119 antibody [28-3] - Microglial marker (AB209064)

Immunohistochemical analysis of formalin fixed paraffin embedded mouse brain labelling TMEM119 with ab209064 at a concentration of 0.1µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a ChromoMap DAB kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab209064 anti-TMEM119 antibody [28-3] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

  • Carrier free

    Anti-TMEM119 antibody [28-3] - Microglial marker - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

28-3

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

IHC-FoFr, IHC-Fr, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

<p>This antibody recognizes mouse Tmem119, a transmembrane protein that has been reported to be a highly specific microglia marker that is not expressed by macrophages or other immune or neural cell types (Bennett et al., 2016&#41;.</p><p>FURTHER INFORMATION ON SPECIFICITY (Chinese Version) available under the product protocols section. This file includes key technical notes of experience when using this product.</p>

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCFoFr" : {"fullname" : "Immunohistochemistry (PFA perfusion fixed frozen sections)", "shortname":"IHC-FoFr"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCFoFr-species-checked": "notRecommended", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "0.1-0.5 µg/mL", "IHCP-species-notes": "<p>Tris-EDTA buffer preferred.</p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "1-5 µg/mL", "IHCFr-species-notes": "<p>We recommend using 0.3-0.5% Triton X-100. Perform heat mediated antigen retrieval before IHC-Fr staining protocol, if the signal is too weak.</p>" }, "Mouse": { "IHCFoFr-species-checked": "testedAndGuaranteed", "IHCFoFr-species-dilution-info": "1-5 µg/mL", "IHCFoFr-species-notes": "<p>Perform heat mediated antigen retrieval with citrate buffer pH 6. Incubate the section with primary antibody at 4 ℃ overnight.</p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "0.1-0.5 µg/mL", "IHCP-species-notes": "<p>Tris-EDTA buffer preferred.</p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "1-5 µg/mL", "IHCFr-species-notes": "<p>We recommend using 0.3-0.5% Triton X-100. Perform heat mediated antigen retrieval before IHC-Fr staining protocol, if the signal is too weak.</p>" }, "Rat": { "IHCFoFr-species-checked": "notRecommended", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "0.1-0.5 µg/mL", "IHCP-species-notes": "<p>Tris-EDTA buffer preferred.</p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "1-5 µg/mL", "IHCFr-species-notes": "<p>We recommend using 0.3-0.5% Triton X-100. Perform heat mediated antigen retrieval before IHC-Fr staining protocol, if the signal is too weak.</p>" } } }

Product details

Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-FoFr, IHC-Fr and IHC-P

Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) was first used in a scientific publication in 2016 and has been cited over 139 times in peer reviewed journals. It's performance in IHC and Immunofluorescence in mouse samples is trusted by the scientific community.

Abcam's high quality manufacturing and validation processes ensure Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

The specificity of Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) has been confirmed by IHC testing in TMEM119 knockout Mouse brain cells.

Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) has 20 independent reviews from customers.

Anti-TMEM119 antibody [28-3] - Microglial marker (ab209064) specifically detects TMEM119 (UniProt ID: Q4V9L6; Molecular weight: 27kDa) and is sold in a convenient trial size to enable initial testing (10 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Conjugation-ready, carrier free format available for antibody clone 28-3 - ab234501.

TMEM119 is a marker for microglia, the resident immune cells of the brain. In Alzheimer's disease (AD) research, TMEM119 is used to differentiate microglia from other brain-resident cells and infiltrating macrophages. Altered TMEM119 expression in AD brains reflects microglial activation and neuroinflammation, making it a valuable tool for studying the immune response and pathology in Alzheimer's disease.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 6.97% L-Arginine
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TMEM119 also known as transmembrane protein 119 plays a role in cell membrane dynamics. It has a molecular mass of approximately 35 kDa. TMEM119 is specifically expressed in microglia in the central nervous system. Microglia serve essential functions in brain homeostasis and immune response. Given its expression profile TMEM119 serves as a marker to identify microglia especially in research focused on neurological tissues. Researchers often utilize techniques like microglial flow cytometry and microglial staining for identification and quantification of microglial populations often in frozen marker studies.
Biological function summary

TMEM119 regulates signaling pathways that maintain microglial identity and function but does not typically form part of larger complexes. It modulates microglial activation states and influences responses to central nervous system injury and inflammation. As a membrane protein it may interact with other surface molecules although specific binding partners are not well-characterized in current literature. Researchers value TMEM119 as a reliable marker in studies aiming to distinguish brain-resident microglia from infiltrating peripheral macrophages.

Pathways

TMEM119 functions as a modulator within inflammatory and neuroimmune pathways. It plays roles in the NF-κB signaling and the neuroinflammatory cascade. Its relationship with proteins like CD68 and Iba1 indicates it may influence pathways tied to immune responses and phagocytosis within nervous system contexts. Understanding the interactions and co-expression of TMEM119 with these proteins helps clarify its contribution to neuroimmune functions.

TMEM119 links with neurological conditions such as Alzheimer's disease and multiple sclerosis. Altered expression of TMEM119 appears in disease states potentially contributing to pathogenesis through disrupted inflammatory responses. Its association with proteins such as TREM2 in Alzheimer's suggests that TMEM119 may play indirect roles in the progression of neurodegeneration. Furthermore high TMEM119 levels in pathological samples provide insights into microglial involvement in disease progression and potential targets for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays an important role in bone formation and normal bone mineralization (PubMed : 20025746, PubMed : 22416756, PubMed : 26207632). Promotes the differentiation of myoblasts into osteoblasts (PubMed : 20025746, PubMed : 22416756, PubMed : 22579779). May induce the commitment and differentiation of myoblasts into osteoblasts through an enhancement of BMP2 production and interaction with the BMP-RUNX2 pathway (PubMed : 21239498, PubMed : 22579779). Up-regulates the expression of ATF4 which plays a central role in osteoblast differentiation (PubMed : 24362451). Essential for normal spermatogenesis and late testicular differentiation (PubMed : 26207632).
See full target information Tmem119

Publications (205)

Recent publications for all applications. Explore the full list and refine your search

Journal of neuroinflammation 22:218 PubMed41024105

2025

Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brains.

Applications

Unspecified application

Species

Unspecified reactive species

Monica Xiong,Lisa A Miosge,Carolina Correa-Ospina,Claudia M Y Yan,Tiffany Cripps,Stefan Bauernfried,Yuanyuan Wang,Maggie Crow,Lucy X Morris,T Daniel Andrews,Andrew Trujillo,Mitchell G Rezzonico,Yuxin Liang,Qixin Bei,Zora Modrusan,Kimberly L Stark,Tracy J Yuen,Brad A Friedman,Jesse E Hanson,Edward M Bertram,Christopher J Bohlen

CNS neuroscience & therapeutics 31:e70565 PubMed40931631

2025

Repopulating Microglia Suppress Peripheral Immune Cell Infiltration to Promote Poststroke Recovery.

Applications

Unspecified application

Species

Unspecified reactive species

Ligen Shi,Lingxiao Lu,Jun Hu,Jiarui Chen,Qia Zhang,Ziyang Jin,Zhen Wang,Zhe Zheng,Jianmin Zhang

Nature 646:1178-1186 PubMed40903578

2025

PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia.

Applications

Unspecified application

Species

Unspecified reactive species

Alena Kozlova,Siwei Zhang,Ari Sudwarts,Hanwen Zhang,Stanislau Smirnou,Seul Kee Byeon,Christina Thapa,Xiaotong Sun,Kimberley Stephenson,Xiaojie Zhao,Brendan Jamison,Moorthi Ponnusamy,Xin He,Julie A Schneider,Akhilesh Pandey,David A Bennett,Zhiping P Pang,Alan R Sanders,Hugo J Bellen,Gopal Thinakaran,Jubao Duan

Communications biology 8:1307 PubMed40883541

2025

SARS-CoV-2 vaccination during pregnancy enhances offspring hippocampal neurogenesis and working memory via IFN-γ-responsive microglia.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaoling Tang,Fangfang Qi,Juntao Zou,Hao Liu,Zejie Zuo,Lingxiao Wang,Na Wang,Zhihui Li,Ashutosh Kumar,Kaihua Guo,Dandan Hu,Zhibin Yao

iScience 28:113130 PubMed40799393

2025

Interferon signaling modulates Down syndrome-associated Alzheimer's disease pathology in a mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Paula Araya,Brian Niemeyer,Kyndal Schade,Lauren N Dunn,Katherine Waugh,Nicolas Busquet,Connie Brindley,Chrisstopher Brown,Caitlin Winkler,Hannah R Lyford,Eleanor C Britton,Michael Ludwig,Julie Siegenthaler,Matthew D Galbraith,Joaquin M Espinosa,Kelly D Sullivan

Nature neuroscience 28:1688-1703 PubMed40659845

2025

Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Alberto Ardura-Fabregat,Lance Fredrick Pahutan Bosch,Emile Wogram,Omar Mossad,Roman Sankowski,Philipp Aktories,Lina Kieger,James Cook,Dilara Hasavci,Hatice Ulupinar,Daniel Brock,Fang Wang,Nicola Iovino,Samuel Wald,Sebastian Preissl,Bahtiyar Yilmaz,Daniel Schnepf,Andrew J Macpherson,Thomas Blank,Katrin Kierdorf,Marco Prinz

Molecular neurodegeneration 20:60 PubMed40426267

2025

Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Xiang,Zhengjiang Qian,Ye Xi,Yanuo Wei,Guangxing Wang,Xia Liu,Zhi-Hao Wang,Zhentao Zhang,Shengxi Wu,Keqiang Ye

Basic & clinical pharmacology & toxicology 137:e70058 PubMed40432346

2025

Eugenol Alleviates Cerebral Ischemia-Reperfusion Injury in Mice by Promoting the Phagocytosis of Microglia via Up-Regulating Tripartite Motif Protein 59.

Applications

Unspecified application

Species

Unspecified reactive species

Mengtian Pan,Xiang Li,Xinjuan Tian,Lele Zixin Yang,Weirong Fang

Theranostics 15:5481-5498 PubMed40303324

2025

BARD1-mediated stabilization of METTL14 promotes retinal neovascularization by m6A-modifying MXD1 mRNA on a YTHDF2-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Xianyang Liu,Shuhao Zeng,Jiayu Meng,Qian Zhou,Fan Cao,Baorui Chu,Chao Wu,Yakun Wang,Hui Feng,Xiaorui Bi,Xinyuan Chen,Wenxian Yang,Meng Tian,Hui Yang,Ke Hu,Shengping Hou

Small (Weinheim an der Bergstrasse, Germany) 21:e2307097 PubMed40249282

2025

HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long-term Survival in Mouse Glioma Model.

Applications

Unspecified application

Species

Unspecified reactive species

Troy A Halseth,Anzar A Mujeeb,Lisha Liu,Kaushik Banerjee,Nigel Lang,Todd Hollon,Minzhi Yu,Mark Vander Roest,Ling Mei,Hongliang He,Maya Sheth,Maria G Castro,Anna Schwendeman
View all publications
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com